Fitch cuts Merck debt outlook to 'Negative' - CNNMoney.com
RonKerr | November 17, 2008 RTT News |
Fitch cuts Merck debt outlook to 'Negative'
CNNMoney.com - The rating agency noted that Merck's cholesterol drug Zocor and osteoporosis drug Fosamax are already facing competition from lower-cost generics, … Fitch cuts Merck's Ratings Outlook to "Negative" from "Stable" Fitch Revises Merck & Co.'s Ratings Outlook to Negative |
